These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7909229)

  • 1. Cytotoxic T-cell response and AIDS-free survival in simian immunodeficiency virus-infected macaques.
    Bourgault I; Villefroy P; Beyer C; Aubertin AM; Levy JP; Venet A
    AIDS; 1993 Nov; 7 Suppl 2():S73-9. PubMed ID: 7909229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques.
    Venet A; Bourgault I; Aubertin AM; Kiény MP; Levy JP
    J Immunol; 1992 May; 148(9):2899-908. PubMed ID: 1349322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques.
    Kaur A; Daniel MD; Hempel D; Lee-Parritz D; Hirsch MS; Johnson RP
    J Virol; 1996 Nov; 70(11):7725-33. PubMed ID: 8892893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar abnormalities of idiotype and immunoglobulin light chain expression and of cell-mediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV)-infected rhesus macaques.
    Grant MD; Whaley MD; Mayne A; Hoffmann GW; Ansari AA
    Immunol Cell Biol; 1996 Feb; 74(1):38-44. PubMed ID: 8934652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th-1-type cytotoxic CD8+ T-lymphocyte responses to simian immunodeficiency virus (SIV) are a consistent feature of natural SIV infection in sooty mangabeys.
    Wang Z; Metcalf B; Ribeiro RM; McClure H; Kaur A
    J Virol; 2006 Mar; 80(6):2771-83. PubMed ID: 16501086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
    Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques.
    Hirsch VM; Santra S; Goldstein S; Plishka R; Buckler-White A; Seth A; Ourmanov I; Brown CR; Engle R; Montefiori D; Glowczwskie J; Kunstman K; Wolinsky S; Letvin NL
    J Virol; 2004 Jan; 78(1):275-84. PubMed ID: 14671109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.
    Dittmer U; Nisslein T; Bodemer W; Petry H; Sauermann U; Stahl-Hennig C; Hunsmann G
    Virology; 1995 Oct; 212(2):392-7. PubMed ID: 7571408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential significance of the cellular immune response against the macaque strain of simian immunodeficiency virus (SIVMAC) in immunized and infected rhesus macaques.
    Voss G; Nick S; Stahl-Hennig C; Coulibaly C; Petry H; Lüke W; Hunsmann G
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2273-81. PubMed ID: 1357081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.
    Kawada M; Tsukamoto T; Yamamoto H; Takeda A; Igarashi H; Watkins DI; Matano T
    J Virol; 2007 May; 81(10):5202-11. PubMed ID: 17344296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
    Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
    Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential CD4+ T-lymphocyte apoptosis and bystander T-cell activation in rhesus macaques and sooty mangabeys during acute simian immunodeficiency virus infection.
    Meythaler M; Martinot A; Wang Z; Pryputniewicz S; Kasheta M; Ling B; Marx PA; O'Neil S; Kaur A
    J Virol; 2009 Jan; 83(2):572-83. PubMed ID: 18987149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection.
    O'Connor D; Friedrich T; Hughes A; Allen TM; Watkins D
    Immunol Rev; 2001 Oct; 183():115-26. PubMed ID: 11782252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of SIV/SMM viral proteins that induce T cell response in experimentally infected rhesus macaques and naturally infected sooty mangabeys by the cellular western blot assay.
    Powell JD; Villinger F; Yehuda-Cohen T; Vuchetich M; McClure HM; Sell KW; Ahmed-Ansari A
    J Med Primatol; 1990; 19(3-4):227-38. PubMed ID: 2231683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection.
    Mothé BR; Horton H; Carter DK; Allen TM; Liebl ME; Skinner P; Vogel TU; Fuenger S; Vielhuber K; Rehrauer W; Wilson N; Franchini G; Altman JD; Haase A; Picker LJ; Allison DB; Watkins DI
    J Virol; 2002 Jan; 76(2):875-84. PubMed ID: 11752176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive role of macaque cytotoxic T lymphocytes during SIV infection: decrease of cellular viremia and increase of asymptomatic clinical period.
    Villada IB; Mortara L; Aubertin AM; Gras-Masse H; Lévy JP; Guillet JG
    FEMS Immunol Med Microbiol; 1997 Sep; 19(1):81-7. PubMed ID: 9322072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of cytotoxic T lymphocyte responses to SIV proteins in SIV-infected macaques using antigen-specific stimulation with recombinant vaccinia and fowl poxviruses.
    Kent SJ; Stallard V; Corey L; Hu SL; Morton WR; Gritz L; Panicali DL; Greenberg PD
    AIDS Res Hum Retroviruses; 1994 May; 10(5):551-60. PubMed ID: 7917517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques.
    Ansari AA; Mayne AE; Sundstrom JB; Bostik P; Grimm B; Altman JD; Villinger F
    J Virol; 2002 Feb; 76(4):1731-43. PubMed ID: 11799168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques.
    Chowdhury A; Hayes TL; Bosinger SE; Lawson BO; Vanderford T; Schmitz JE; Paiardini M; Betts M; Chahroudi A; Estes JD; Silvestri G
    J Virol; 2015 Sep; 89(17):8677-86. PubMed ID: 26063417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased frequency of cytomegalovirus (CMV)-specific CD4+ T lymphocytes in simian immunodeficiency virus-infected rhesus macaques: inverse relationship with CMV viremia.
    Kaur A; Hale CL; Noren B; Kassis N; Simon MA; Johnson RP
    J Virol; 2002 Apr; 76(8):3646-58. PubMed ID: 11907204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.